ACCURACY OF IN-VIVO AND IN-VITRO TESTS

Any new diagnostic test should be validated by standard procedures, an d must be validated by the outcome of double-blind, placebo-controlled food challenges (DBPCFC), except in infants, with strict adherence to the EAACI guidelines. Available data should include calculations on s ensitivity, specificity, predictive values, and concordance and must b e calculated on the basis of patients in whom the diagnosis has been e stablished by DBPCFC. Furthermore, data on possible cross-reacting foo ds and their clinical relevance should be available. (C) Munksgaard 19 98.